At an event hosted by BioPharma Dive, drugmaker executives and investors discussed the importance of focus, smart spending ...
The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...
Politics will matter greatly for the biotechnology and healthcare sectors. On Thursday, President-elect Trump said that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback